| S.No. | Name of Candidate | Thesis Title | Area | Start of Ph.D.-Year of Award | Status |
| 1 | Venkatesha Perumal R | Design Synthesis and pharmacological evaluation of novel serotonergic 5HT3 receptor antagonist as potential agents for the treatment of cancer chemotherapy induced emesis | Drug design and Development, Synthetic Medicinal Chemistry | August, 2001 -September, 2005 | Completed |
| 2 | RajKumar R | Behavioural Neuropharmacological Studies of Selected Serotonin Type-3 Receptor Antagonists as Potential Anti-depressants | Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) | August, 2004 - March 2008 | Completed |
| 3 | Dilip Kumar Pandey | Neurobehavioural and Neurochemical Evaluation of Selected Monoaminergic Modulators in Animal Models of Comorbid Depression and Anxiety | Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) | August, 2007 - March 2011 | Completed |
| 4 | T. Devadoss | Novel Quinoxaline Carboxamides: Design, Synthesis And Neuro-Pharmacological Evaluation as Anti-depressants, Anxiolytic And in the Management of Cancer Chemotherapy-Induced Nausea and Vomiting | Drug design and Development, Synthetic Medicinal Chemistry | December, 2007 - January 2012 | Completed |
| 5 | Shvetank Bhatt | Behavioural and Neuropharmacological Screening of Potential Serotonergic Ligands for Co-morbid Depression, Anxiety and Related Disorders such as Cancer Chemotherapy Induced Nausea and Vomiting (CINV) | Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) | October, 2008 - March, 2015 | Completed |
| 6 | Arghya K Dhar | Novel Neuro-Pharmacological Agents for the Treatment of Depression, Anxiety, Cognitive dysfunction and Cancer Chemo- Therapy Induced Emesis: Design synthesis and Screening af Potential Serotonergic Modulators | Drug design and Development, Synthetic Medicinal Chemistry | January, 2010 - May, 2016 | Completed |
| 7 | Ankur Jindal | Behavioral and Neuropharmacological Screening of Phosphodiesterase4 (PDE4) Inhibitors for Anti-depressant and Anxiolytic Potential | Neuropsycho-pharmacology division, (Drug discovery, standardization and development of new animal model) | January, 2010 - December, 2015 | Completed |
| 8 | Muthu V. Sudali | Design, Synthesis and Pharmacological Evaluation of Novel Phosphodiesterase-IV inhibitors for their Anti-depressant and Anxiolytic Potential | Drug design and Development, Synthetic Medicinal Chemistry | June, 2010 - Octiber, 2015 | Completed |
| 9 | Sourabh Mundra | Design, Synthesis and screening of Potential Anti-malarial Agents. | Drug design and Development, Synthetic Medicinal Chemistry | September, 2010 - June, 2017 | Completed |
| 10 | Deepali Gupta | Behavioral and Neuro-pharmacological Screening of Potential Serotonergic Ligands for Co-morbid Depression | Neuropsycho-pharmacology, (Drug discovery, standardization and development of new animal model) | August, 2011 - April, 2017 | Completed |
| 11 | Yeshwant Kurhe | Behavioral and Neuropharmacological Screening of Potential Serotonergic Modulators for Depression Comorbid with Obesity | Neuropsycho-pharmacology, (Drug discovery, standardization and development of new animal model) | January, 2012 - January, 2018 | Completed |
| 12 | Sushil Yadav | Isolation and Characterization of Genetic Variants of Beta Casein From Cow Milk and to Study Their Effects on Osteoporosis | Neuropsycho-pharmacology, Veterinary Pharmacology and Biotechnology | August, 2012 - Oct., 2019 | Completed |
